Litcius/Paper detail

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization

Zuzana Tóthová, Martina Šemeláková, Zuzana Solárová, Jana Tomc, Nataša Debeljak, Peter Solár

2021International Journal of Molecular Sciences112 citationsDOIOpen Access PDF

Abstract

Erythropoietin (EPO) is a glycoprotein cytokine known for its pleiotropic effects on various types of cells and tissues. EPO and its receptor EPOR trigger signaling cascades JAK2/STAT5, MAPK, and PI3K/AKT that are interconnected and irreplaceable for cell survival. In this article, we describe the role of the MAPK and PI3K/AKT signaling pathways during red blood cell formation as well as in non-hematopoietic tissues and tumor cells. Although the central framework of these pathways is similar for most of cell types, there are some stage-specific, tissue, and cell-lineage differences. We summarize the current state of research in this field, highlight the novel members of EPO-induced PI3K and MAPK signaling, and in this respect also the differences between erythroid and non-erythroid cells.

Topics & Concepts

Erythropoietin receptorErythropoietinProtein kinase BPI3K/AKT/mTOR pathwayMAPK/ERK pathwaySignal transductionCell biologyHaematopoiesisBiologyCancer researchStem cellEndocrinologyErythropoietin and Anemia TreatmentErythrocyte Function and PathophysiologyPARP inhibition in cancer therapy
The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization | Litcius